Ocular Hypertension
📧 Sign up to get email alerts when something new happens for Ocular Hypertension.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-02-06EMA Authorised: Azarga (brinzolamide;timolol maleate) — Novartis Europharm Limited
EMA authorised Azarga, a fixed-dose combination of brinzolamide and timolol, for open-angle glaucoma and ocular hypertension; applicant: Nov…
-
EMA approval · 2026-02-05EMA Authorised: DuoTrav (travoprost;timolol) — Novartis Europharm Limited
The EMA authorised DuoTrav, a fixed-dose combination eye drop of travoprost and timolol by Novartis Europharm Limited, for open-angle glauco…
-
FDA approval · 2026-01-28FDA Approved: YUVEZZI — Original Application (Visus Therapeutics, Inc.)
The FDA approved YUVEZZI, a fixed-dose combination ophthalmic preparation of carbachol and brimonidine tartrate, under an original NDA from …
-
FDA approval · 2026-01-27FDA Approved: IDOSE TR — Supplemental Application (Glaukos Corporation)
FDA approved a supplemental application for IDOSE TR, a travoprost intracameral product from Glaukos Corporation.
-
EMA approval · 2026-01-23EMA Authorised: Travatan (travoprost) — Novartis Europharm Limited
EU marketing authorisation granted for Travatan eye drops (travoprost) by Novartis Europharm Limited for glaucoma (open-angle) and ocular hy…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2026-01-23EMA Authorised: Simbrinza (brinzolamide;brimonidine tartrate) — Novartis Europharm Limited
The EMA authorised Simbrinza, a fixed-dose combination of brinzolamide and brimonidine tartrate, for the treatment of ocular hypertension an…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery Alone [Phase 4]
Phase 4 clinical trial evaluating the safety and efficacy of iDose TR used with cataract surgery versus cataract surgery alone is currently …
-
EMA approval · 2026-01-15EMA Authorised: Rhokiinsa (netarsudil) — Santen Oy
The EMA authorised Rhokiinsa (netarsudil) by Santen Oy for open-angle glaucoma and ocular hypertension.
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: Ph2 Placebo-Controlled Study for Safety & Ocular Efficacy of SBI-100 Ophthalmic Emulsion in Pts w/ Elevated Eye Pressure [Phase 2]
Phase 2 placebo-controlled study evaluating safety and ocular efficacy of SBI-100 Ophthalmic Emulsion in patients with elevated eye pressure…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Efficacy and Safety of HUC3-637 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension [Phase 3]
This clinical trial update reports an ongoing Phase 3 study assessing the efficacy and safety of HUC3-637 for Primary Open Angle Glaucoma an…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Effect of Raised End-Tidal pCo2 on Choroidal Volume [NA]
A University of Pittsburgh trial is examining whether raised end-tidal CO2 influences choroidal volume in the context of intraocular pressur…
-
CLINICAL_TRIALS trial_result · 2026-01-02Clinical Trial Update: Efficacy and Safety Assessment of T4090 Ophthalmic Solution Versus Rhopressa® Ophthalmic Solution in Patients With Open-angle Glaucoma or Ocular Hypertension [Phase 2]
This Phase 2 trial compared efficacy and safety of T4090 ophthalmic solution to Rhopressa in Open-angle glaucoma or ocular hypertension; res…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: A Comparative Study of Intraocular Pressure Control Using Selective Laser Trabeculoplasty and Latanoprost as Initial Treatments for Primary Open Angle Glaucoma and Ocular Hypertension in Lagos State University Teaching Hospital [NA]
This ClinicalTrials.gov entry describes a recruiting study at Lagos State University Teaching Hospital comparing selective laser trabeculopl…
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: Implementing AI-based Glaucoma Screening Within Federally Qualified Health Centers [NA]
A clinical trial to implement AI-based glaucoma screening in Federally Qualified Health Centers, currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Evaluate Efficacy, Safety, Tolerability and Biodegradation of PA5346 Ocular Implant in Patients With Open-Angle Glaucoma or Ocular Hypertension [Phase 1]
Phase 1 clinical trial update evaluating the PA5346 Ocular Implant for safety, tolerability, biodegradation and potential efficacy signals i…
-
FDA approval · 2025-12-17FDA Approved: LATANOPROST OPHTHALMIC SOLUTION — Original Application (Lifestar Pharma LLC)
FDA approved an original application for latanoprost ophthalmic solution from Lifestar Pharma LLC, providing a generic version of latanopros…
-
FDA approval · 2025-12-17FDA Approved: TRAVOPROST OPHTHALMIC SOLUTION — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved Travoprost Ophthalmic Solution under an Original ANDA filed by Alembic Pharmaceuticals, indicated to reduce intraocular pressur…
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Direct Selective Laser Trabeculoplasty in Ethnic Chinese Population [NA]
A clinical trial evaluating direct selective laser trabeculoplasty in an ethnic Chinese population is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-12-11Clinical Trial Update: Quick Measure Study for iCare ST500 and iCare IC200 [NA]
A completed clinical trial evaluating the intraocular pressure measurement devices iCare ST500 and iCare IC200 sponsored by Icare Finland Oy…
-
FDA approval · 2025-11-21FDA Approved: BRIMONIDINE TARTRATE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for BRIMONIDINE TARTRATE submitted by Sandoz Inc.
-
CLINICAL_TRIALS trial_result · 2025-11-18Clinical Trial Update: Next Generation Rocklatan [Phase 2]
A Phase 2 study of the next generation Rocklatan for open angle glaucoma and ocular hypertension has completed.
-
CLINICAL_TRIALS research · 2025-10-20Clinical Trial Update: Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhine) [Phase 3]
Phase 3 trial evaluating the safety and efficacy of the Bimatoprost Implant System used in combination with the SpyGlass intraocular lens, c…
-
CLINICAL_TRIALS research · 2025-10-20Clinical Trial Update: Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhone) [Phase 3]
Phase 3 clinical trial evaluating the safety and efficacy of the Bimatoprost Implant System used with the SpyGlass intraocular lens, compare…
-
CLINICAL_TRIALS trial_result · 2025-10-15Clinical Trial Update: Latanoprost Eluting Contact Lens for Treating Glaucoma and Ocular Hypertension [Phase 1]
Phase 1 clinical trial of a latanoprost-eluting contact lens for treating glaucoma and ocular hypertension has been terminated.
-
FDA approval · 2025-10-09FDA Approved: TRAVATAN Z — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for TRAVATAN Z (travoprost) submitted by Novartis Pharmaceuticals Corporation, resulting in chan…